Table 3 Incidence of remifentanil-induced chest wall rigidity and other adverse effects
Thio-Remi (n = 30) | Pro-Remi (n = 30) | Remi-Thio (n = 30) | Remi-Pro (n = 30) | P value | |
|---|---|---|---|---|---|
Chest wall rigidity | 9 (30%) | 4 (13.3%) | 16 (53.3%) | 17 (56.7%) | 0.001* |
Desaturation | 2 (6.7%) | 2 (6.7%) | 8 (26.7%) | 8 (26.7%) | 0.034* |
Cough | 2 (6.7%) | 4 (13.3%) | 1 (3.3%) | 2 (6.7%) | 0.516 |